Oral Anticoagulation and Factor VIII Replacement Therapy in Patients With Hemophilia Undergoing Pulsed-Field or Radiofrequency Catheter Ablation for Atrial Fibrillation.

Sanghamitra Mohanty Michela Casella Paolo Compagnucci Prem Geeta Torlapati Vincenzo Mirco La Fazia Carola Gianni Bryan MacDonald Angel Quintero Mayedo Domenico Giovanni Della Rocca John Allison Mohamed Bassiouny G Joseph Gallinghouse John D Burkhardt Rodney Horton Amin Al-Ahmad Luigi Di Biase Antonio Dello Russo Andrea Natale

Circ Arrhythm Electrophysiol

Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, TX (S.M., P.G.T., V.M.L.F., C.G., B.M., A.Q.M., J.A., M.B., G.J.G., J.D.B., R.H., A.A.-A., A.N.).

Published: October 2024

Download full-text PDF	Source
http://dx.doi.org/10.1161/CIRCEP.124.012921	DOI Listing

Publication Analysis

Top Keywords

oral anticoagulation

anticoagulation factor

factor viii

viii replacement

replacement therapy

therapy patients

patients hemophilia

hemophilia undergoing

undergoing pulsed-field

pulsed-field radiofrequency

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!